Can Biomarkers Improve Cardiovascular Risk Assessments in RA? The TARGET (Treatments Against RA and Effect on FDG PET/CT) trial showed that different treatment strategies equally benefited arterial inflammation (by FDG-PET) in rheumatoid arthritis. https://t.co/NTI57kTtAy https://t.co/idf4qTtKcw